Compare PUK & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PUK | BDX |
|---|---|---|
| Founded | 1848 | 1897 |
| Country | Hong Kong | United States |
| Employees | 15338 | N/A |
| Industry | Life Insurance | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.7B | 43.0B |
| IPO Year | N/A | 1997 |
| Metric | PUK | BDX |
|---|---|---|
| Price | $27.63 | $156.47 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $186.00 |
| AVG Volume (30 Days) | 1.3M | ★ 2.4M |
| Earning Date | 03-26-2026 | 05-07-2026 |
| Dividend Yield | 1.68% | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.92 | $3.02 |
| P/E Ratio | ★ $23.76 | $622.00 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $24.40 | $140.11 |
| 52 Week High | $34.03 | $213.08 |
| Indicator | PUK | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 50.92 | 60.36 |
| Support Level | $27.20 | $153.27 |
| Resistance Level | $28.29 | $159.79 |
| Average True Range (ATR) | 0.43 | 3.94 |
| MACD | 0.29 | 1.19 |
| Stochastic Oscillator | 75.77 | 87.67 |
Originally established in 1848 as the Prudential Mutual Assurance, Investment, and Loan Association, Prudential has changed a lot since. Set up to sell life insurance and loans to the middle class, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life around 1985. During its time as owner of Jackson, Prudential focused on building a simple chassis-style product portfolio that allowed customers to choose from a variety of add-ons. The company also became renowned for its focus on building the internal capabilities required to support its strong product offerings, including compelling technology and a large well-trained wholesale salesforce.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.